House Appropriations Committee directs FDA to revamp new drug development process; House passes ~$7B agency funding bill 213-210.
The House Appropriations Committee told the FDA to reform the way it signs off on new clinical trials, reflecting a broader effort to ensure the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Drug companies, patient groups urge FDA to pause commissioner’s voucher program
Prior authorization bill now eligible for House fast track
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
House spending panel proposes slight raise for NIH in 2027
House Appropriations Committee takes aim at CMS' WISeR pilot
USFDA moots ways to reduce animal testing for cancer drugs
As leadership changes create more instability at the FDA, here’s what one former agency official thinks it will take to keep…
Monitoring trials in real time may help shorten the time interval between trial phases.
Makary pointed to three bottlenecks: hospital contracting, ethical reviews and approvals and the Investigational New Drug…
The White House has used the program to reward companies that help its political goals.
The White House is reviewing a new FDA-biopharma user fee deal that includes
The Food and Drug Administration must remove barriers between progress and rare disease patients whose lives hang in the balance.
